Narrow Results

Lupus Research Institute awards $1-million grants to discover what causes lupus.

AstraZeneca and Pharmacyclics enter clinical trial collaborations in oncology.

Singapore — the global launch pad for game-changing clinical trials initiative.

MedImmune strengthens immuno-oncology capabilities with acquisition of Definiens.

AOP Orphan to bring Thromboreductin^® to the Russian market.

PPP launched to improve prevention of women's cancers and quality of cancer registries in Latin America and the Caribbean.

National Heart Research Institute Singapore and Thermo Fisher Scientific team up to further enhance stem cell research techniques.

Felicitex Therapeutics and Selvita initiate strategic collaboration to target cancer quiescence.

WomenHeart launches first campaign to improve quality of life and reduce hospitalizations for women living with heart failure.

President's Science and Technology Awards 2014 honors outstanding scientific talent for their contributions to Singapore's R&D landscape.

Abcam signs exclusive partnership agreement with A*STAR’s Institute of Molecular and Cell Biology.

MED-EL founders Ingeborg Hochmair, PhD, and Professor Erwin Hochmair awarded 2015 Russ Prize from the National Academy of Engineering.

Epic Sciences receives CLIA Certification for its cancer diagnostics laboratory.

MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology.

Daiichi Sankyo receives approval in Japan for the manufacture and marketing of methemoglobinemia treatment.

Aptuit to divest two non-core sites; facilitates reinvestment and accelerated growth in core area of integrated solutions.

Immune Therapeutics, Inc. enters agreement with KRS Global Biotechnology, Inc.

Collaboration between Delta Group and Institute of Bioengineering and Nanotechnology targets the global medical technology market.

SINGAPORE – Singapore Health Sciences Authority Approves First Immuno-Oncology Treatment, Bristol-Myers Squibb's Opdivo^® (nivolumab), for Advanced-Stage Lung Cancer

SINGAPORE – The Award of a $7.5 Million Translational Clinical Research Grant from National Medical Research Council Launches the Flagship Programme in Liver Cancer

SINGAPORE – Scientists Discover New Technology Breakthrough in Fighting Viral Diseases

UNITED STATES – BioTek Instruments and Merck Combine Forces for Long-Term Live Cell Experiments

UNITED STATES – Aspirin Use May Help Prevent Bile Duct Cancer, Mayo-Led Study Finds

UNITED STATES – Widespread Loss of Ocean Oxygen to Become Noticeable in 2030s

UNITED KINGDOM – Axol Bioscience Launches iPSC-Derived Astrocyte Kits

TAIWAN – A Natural Plant Metabolite Derivative Q2-3 Efficiently Prevents Metastasis of Mammary Tumour Cells

VIETNAM – Second VINMEC International Hospital Implements Solution for Patient Safety and Quality Management

AbbVie's First Manufacturing Facility in Asia

The QUATTROR® Dual Mobility Cup: A Technical Revolution in Total Hip Arthroplasty

The following topics are under this section:

• Collaborative launch of translational R&D hub to enhance clinical diagnostic development efforts
• Development of artificial intelligence (AI) tools and analytics platforms for improving cell therapy and immuno-oncology
• Entering the China market to provide regional support
• New funding help to support expansion of eye treatment facilities across Vietnam
• Alarm raised over increased targeted cyberattacks against pharmaceutical industry
• Joint fundraising acceleration programme to support development of tech companies and expand investor community
• Asia’s first FemTech innovations group to offer healthcare solutions unique to Asian women
• Population-Based Public Health initiative in Singapore leverages on digital health platforms
• Malaysian subsidiary of major biopharmaceutical company receives GMP Certification for compliance
• E-paper technology to support unmanned retail outlet in Hong Kong Science Park
• Novena Global Lifecare acquires three Taiwanese healthcare players